178606-66-1; U-104; 4-(3-(4-fluorophenyl)ureido)benzenesulfonamide; 1-(4-fluorophenyl)-3-(4-sulfamoylphenyl)urea; SLC-0111; 4-{[(4-Fluorophenyl)carbamoyl]amino}benzenesulfonamide; NSC-213841; SLC0111; mst-104; U104; ANM9DBL9JT; NSC213841; C13H12FN3O3S; CHEMBL1615281; 4-{[(4'-Fluorophenyl)Carbamoyl]Amino}Benzenesulfonamide; U 104; 4-[[[(4-Fluorophenyl)amino]carbonyl]amino]benzenesulfonamide; 4-[3-(4-Fluorophenyl)ureido]benzenesulfonamide; 4-((((4-Fluorophenyl)amino)carbonyl)amino)benzenesulfonamide; Benzenesulfonamide, 4-((((4-fluorophenyl)amino)carbonyl)amino)-; Benzenesulfonamide, 4-[[[(4-fluorophenyl)amino]carbonyl]amino]-; WWZ; 3n4b; UNII-ANM9DBL9JT; SCHEMBL672955; GTPL10149; EX-A904; 4-[[[(4-Fluorophenyl)amino]carbonyl]amino]-benzenesulfonamide; HMS3651H21; HMS3872E13; BCP14895; ZINC1752601; BDBM50334354; MFCD00159265; s2866; 4-fluorophenylureido-benzenesulfonamide; AKOS001123930; CCG-267573; compound 7 [PMID: 21361354]; CS-4495; NSC 213841; SB19580; NCGC00379154-03; AC-32932; AS-66547; HY-13513; FT-0699833; SW220124-1; U-104, >=98% (HPLC); U-104;NSC213841;MST104; A14959; Carbonic Anhydrase IX/XII Inhibitor II(U-104); EN300-6472708; A881383; J-690246; (3?,5?)-3,14,17-Trihydroxycard-20(22)-enolide; 3-(4-FLUOROPHENYL)-1-(4-SULFAMOYLPHENYL)UREA; Q27467365; Z55286485; 4-(((4-Fluoroanilino)carbonyl)amino)benzenesulfonamide; 4-{[(4''-Fluorophenyl)carbamoyl]amino}benzenesulfonamide; 4-[[[(4-Fluorophenyl)amino]carbonyl]amino]-benzesulfonamide